Companies / Santa Cruz Biotechnology / Npl4 (D-1) Alexa Fluor® 790
Santa Cruz Biotechnology

Npl4 (D-1) Alexa Fluor® 790 | Santa Cruz Biotechnology

mouse monoclonal IgG1; Npl4 Antibody (D-1) is an IgG1 κ mouse monoclonal Npl4 antibody (also designated Npl4 antibody) that detects the Npl4 protein of mouse, rat and human origin by WB, IP, IF and ELISA. Npl4 Antibody (D-1) is available as both the non-conjugated anti-Npl4 antibody form, as well as multiple conjugated forms of anti-Npl4 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The NPL4 gene encodes the 608-amino acid, endoplasmic reticulum and nuclear membrane protein Npl4 that forms a complex with p97/Cdc48p and Ufd1p. This complex plays a role in IP(3) receptor processing by recognizing ubiquitinated IP(3) receptors in the endoplasmic reticulum and delivering them to the proteasome for degradation. The Npl4 protein contains 8 potential N-myristoylation sites, 5 potential N-glycosylation sites, several phosphorylation sites, and a C-terminal zinc finger motif. This protein is 96% homologous to the rat Npl4 protein, 44% homologous to the Caenorhabditis elegans Npl4 protein, and 34% homologous to the Saccharomyces cerevisiae Npl4 protein. Mutations in the NPL4 gene cause defects in nuclear envelope morphology, nuclear protein import, and nuclear poly(A) RNA export.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.